Top Markets
#1 Akedo Akedo +71.59%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.61%
#4 Cross Cross +34.10%
#5 Black Phoenix Black Phoenix +33.95%
#6 Cap Cap +29.61%
#7 Velvet Velvet +26.32%
#8 Ravencoin Ravencoin +17.91%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.35%
#10 DoubleZero DoubleZero +12.07%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
HVIVO plc HVIVO plc

HVIVO plc

HVO
Classifica tra le azioni #39192
hVIVO plc (HVO) operates as a premier full-service Contract Research... hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of clinical development services to a wide-ranging and growing client base, which includes seven of the world's ten largest biopharmaceutical companies. A key specialisation for hVIVO is orchestrating human challenge trials across numerous infectious and respiratory diseases, utilising its advanced, London-based quarantine facility, the largest of its kind globally. Additionally, the company offers extensive virology and immunology laboratory services through its hLAB division. Through its German subsidiary, CRS, hVIVO manages a 120-bed capacity across sites in Mannheim and Kiel, delivering early-phase clinical trial expertise, including first-in-human and proof-of-concept studies. Its other subsidiary, Venn Life Sciences, contributes to the biopharma sector by providing specialist early drug development consulting and biometry services. The Group collectively offers integrated drug development solutions, covering stages from preclinical research up to Phase II trials, supported by patient recruitment via FluCamp. Moreover, its five clinical sites facilitate outpatient Phase II and III trials, ensuring a streamlined and effective transition from drug discovery to late-stage development.
Prezzo delle azioni
$0.08850547
Capitalizzazione di mercato
$609.27K
Variazione (1 giorno)
-2.92%
Variazione (1 anno)
-36.17%
Paese
GB
Scambia HVIVO plc (HVO)

Categoria

Healthcare
Storico del prezzo dell'azione per HVIVO plc (HVO)
Prezzo di chiusura più alto: $0.09 il 2026-08-01

Prezzo di chiusura più basso: $0.55 il 2012-12-01
Storico del prezzo dell'azione di HVIVO plc dal 2012 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 25.50%
2025 -69.91%
2024 -3.74%
2023 98.73%
2022 -51.22%
2021 -10.78%
2020 335.59%
2019 194.91%
2018 -84.83%
2017 -45.35%
2016 -9.46%
2015 14.83%
2014 -31.84%
2013 -23.92%
2012 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $503.68 29.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $840.68 28.85%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $725.45 6.21%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.06 11.35%
BE